跳至主要内容
临床试验/NCT01484392
NCT01484392已完成不适用

Determinants of Compliance With Glaucoma Therapy

Legacy Health System1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2006年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Compliance with glaucoma medication at 1 month

研究概览

简要总结

The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • open angle glaucoma
  • be well controlled on current medical therapy
  • be using a prostaglandin analogue

排除标准

  • 未提供

结局指标

主要结局

Compliance with glaucoma medication at 1 month

时间窗: 1 month after enrollment

Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

Compliance with glaucoma medication at 3 months

时间窗: 3 months after enrollment

Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven L. Mansberger

Associate Scientist

Legacy Health System

研究点 (1)

Loading locations...

相似试验

Determinants of Compliance With Glaucoma Therapy | 临床试验